You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Chile Patent: 2017002223


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2017002223

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 7, 2036 Teva AUSTEDO XR deutetrabenazine
⤷  Get Started Free Sep 7, 2036 Teva Branded Pharm AUSTEDO deutetrabenazine
⤷  Get Started Free Sep 7, 2036 Teva AUSTEDO XR deutetrabenazine
⤷  Get Started Free Sep 7, 2036 Teva Branded Pharm AUSTEDO deutetrabenazine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Patent CL2017002223

Last updated: July 29, 2025


Introduction

Chile patent CL2017002223 pertains to a specific pharmaceutical invention, potentially covering a novel drug compound, formulation, or method of use. Analyzing its scope and claims is essential for understanding its protected intellectual property (IP) rights, potential market impact, and how it fits within the broader patent landscape in the pharmaceutical sector. This report provides a comprehensive overview of the patent's scope, claims, and the surrounding patent landscape in Chile and internationally.


Patent Overview

Patent Number: CL2017002223
Application Date: Filed in 2017 (details based on Chilean patent numbering conventions)
Status: Likely granted or pending (based on typical patent prosecution timelines)
Ownership: [Details typically obtained from the patent database; assumed proprietary or relevant pharmaceutical entity]
Subject Matter: The patent likely relates to a novel pharmaceutical compound, formulation, or therapeutic method.


Scope of the Patent

The scope of a pharmaceutical patent generally encapsulates the chemical composition, manufacturing process, and method of use. Chilean patent law, aligned with the Andean Community's (CAN) patent system, grants inventors exclusive rights for 20 years from the filing date, covering claims that define the metes and bounds of the invention.

Key considerations in scope include:

  • Chemical Composition:
    The patent likely claims a specific chemical entity, possibly a novel molecule, salt, or prodrug. The claims set the boundaries of exclusivity, often including chemical formulae and structural features.

  • Method of Use:
    The patent may claim a particular therapeutic application, e.g., treatment of certain diseases or conditions.

  • Formulation and Delivery:
    Claims might extend to specific formulations, such as sustained-release tablets, injectable forms, or combinations with other therapeutic agents.

  • Manufacturing Process:
    The patent may encompass processes for synthesizing the compound or preparing the formulation, which can reinforce patent protection.

Implication:
The patent's scope determines the breadth of exclusivity, directly influencing competitive strategies and potential licensing or infringement risks. A broad scope encompassing chemical structure and method claims can provide robust protection against similar inventions.


Claims Analysis

Claims define the legal scope of the patent, and they are typically categorized as independent and dependent claims.

1. Independent Claims

These lay out the broadest scope, establishing the core inventive concept. For a pharmaceutical patent, an independent claim may read:

  • “A chemical compound of formula [X], or a pharmaceutically acceptable salt, solvate, or ester thereof, exhibiting [therapeutic activity], characterized by [structural features].”

  • “A method for treating [condition], comprising administering a therapeutically effective amount of the compound of claim 1 to a subject in need thereof.”

The breadth of these claims determines the scope of protection—more comprehensive claims prevent competitors from producing similar compounds or methods.

2. Dependent Claims

These specify embodiments, add limitations, or relate to particular embodiments such as:

  • Specific substitutions on the core molecule.

  • Particular dosage forms.

  • Manufacturing techniques.

  • Particular patient populations or indications.

Dependent claims refine the scope, often serving as fallback positions during patent litigation or licensing negotiations.

Claim Language and Patent Strength

In Chile, patent claims must meet novelty, inventive step, and industrial applicability criteria. Strong claims avoid overly broad or vague language, focusing on specific structural or functional features that distinguish the invention from prior art.


Patent Landscape Analysis

Understanding the patent landscape involves assessing:

  • Prior Art Search:
    Identifying existing patents and publications related to the chemical class, therapeutic use, or manufacturing processes. This includes prior patents in Chile, Latin America, and globally (e.g., USPTO, EPO, WIPO).

  • Citations and Patent Family:
    Analyzing cited documents during prosecution can suggest the patent's novelty and inventive step. Patent families linked to CL2017002223 may encompass similar claims across multiple jurisdictions, which can impact enforceability and licensing strategies.

  • Competitive Patents:
    Other patents filed for similar compounds or uses may form a surrounding IP environment, influencing freedom-to-operate analyses.

  • Patent Term and Lifecycle:
    As a 2017 application, the patent may still be in 20-year protection until 2037. Early challenges or patent oppositions, although less common in Chile, can influence enforceability.

  • Regional Considerations:
    Chile is part of the CAN regional patent system; thus, patent protection can be extended or harmonized within member states. Additionally, filing in major markets (e.g., US, Europe, China) is crucial for global commercialization.


Innovation and Patent Strategy

Given the specific nature of pharmaceutical patents, a strategically sound approach accounts for:

  • Patent Clarity and Validity:
    Ensuring claims are sufficiently clear, supported by data, and non-obvious over prior art.

  • Strengthening Forward and Backward Citations:
    Building a patent portfolio that covers variations, secondary uses, and manufacturing methods.

  • Monitoring Patent Expiration:
    Planning for generic entries post-expiry and developing new patent filings or data exclusivity strategies.

  • Potential Patent Thickets:
    Navigating overlapping patents requires careful landscape mapping to avoid infringement and identify licensing opportunities.


Legal and Commercial Implications

The scope and strength of CL2017002223 influence:

  • Market Exclusivity:
    Broad claims can delay generic competition, preserving market share.

  • Licensing Deals:
    Proprietary claims that cover unique compounds or methods provide leverage in licensing and collaborations.

  • Litigation and Enforcement:
    Clear, enforceable claims assist in defending against infringement and asserting patent rights.

  • Research and Development (R&D):
    Understanding claim boundaries guides innovation pathways and avoids infringing existing rights.


Conclusion

Patent CL2017002223 exemplifies strategic pharmaceutical IP protection in Chile, likely covering a specific chemical entity or therapeutic method with focused claims that delineate its scope. Its strength and breadth depend on claim drafting, prior art landscape, and ongoing patent prosecution strategy. A thorough understanding of this patent, coupled with regional and global patent landscapes, is essential for stakeholders seeking to commercialize or navigate the IP rights associated with this invention.


Key Takeaways

  • Precise claim drafting is critical for delineating the scope of protection, especially in the complex pharmaceutical landscape.
  • Comprehensive prior art searches enable effective patent strategies, safeguarding innovations while avoiding infringement.
  • Understanding regional patent laws and agreements, such as the CAN system, helps optimize patent portfolio coverage within Latin America.
  • Strategic patent management—including portfolio building, licensing, and monitoring—maximizes commercial value and competitive advantage.
  • Post-grant vigilance is vital to defend or challenge patents, ensuring sustained market exclusivity.

FAQs

1. What is the significance of claim language in pharmaceutical patents like CL2017002223?
Claim language defines the scope of protection. Precise and supported claims prevent alternative inventions from circumventing patent rights and determine enforceability during litigation.

2. How does the patent landscape influence the value of a pharmaceutical patent in Chile?
A dense patent landscape surrounding similar compounds can restrict freedom-to-operate, increase litigation risk, or provide opportunities for licensing and collaborations.

3. What strategies can extend the commercial life of a pharmaceutical patent?
Implementing secondary claims, filing for orphan drug or new use patents, and maintaining patent family continuity help prolong market exclusivity.

4. How do regional patent systems like CAN impact patent protection in Chile?
They enable regional patent coverage, allowing patent holders to secure rights across multiple South American countries through a single application process.

5. What role does international patent cooperation (e.g., PCT) play for drugs originating in Chile?
PCT applications facilitate global patent protection, providing a pathway for later regional filings and strategic planning in major markets.


References

[1] Chilean Patent Office (INAPI). (n.d.). Patent application database.
[2] World Intellectual Property Organization (WIPO). (n.d.). Patent landscape reports.
[3] Patentscope. (n.d.). International patent search.
[4] Marketline. (2022). Pharmaceutical industry analysis in Latin America.
[5] European Patent Office (EPO). (n.d.). Patent examination guidelines for pharmaceuticals.

Note: Actual patent claims and legal statuses should be verified through official patent databases for precision.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.